Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Reis-Filho, JS

Class:Id	Person:2011697
_displayName	Reis-Filho, JS
_timestamp	2011-11-22 14:28:04
created	[InstanceEdit:2011698] Rothfels, K, 2011-11-22
firstname	Jorge S
initial	JS
surname	Reis-Filho
(author)	[LiteratureReference:2011995] FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer [LiteratureReference:2011997] FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas [LiteratureReference:2023815] Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets [LiteratureReference:5672195] Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF [LiteratureReference:9646758] Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification [LiteratureReference:9704742] Analysis of PALB2/FANCN-associated breast cancer families [LiteratureReference:9725580] p63 expression in normal skin and usual cutaneous carcinomas [LiteratureReference:9945039] Cytokeratin 5/6 in normal human breast: lack of evidence for a stem cell phenotype
[Change default viewing format]

No pathways have been reviewed or authored by Reis-Filho, JS (2011697)